We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bones May Mend Faster Without Bone Marrow

By HospiMedica staff writers
Posted on 15 Apr 2008
A new study in rats suggests that removing some bone marrow with a syringe could promote rapid self-healing in weakened or fractured bones, if followed up with injections of a bone growth hormone. More...


Researchers at Yale University (New Haven, CT, USA) postulated that parathyroid hormone (PTH, a bone anabolic hormone) enhances the formation of new bone that forms after marrow ablation. The researchers subjected the left femur of rats to mechanical marrow ablation, and the right femur to a sham operation, and injected the animals daily with PTH or vehicle for 1, 2, or 3 weeks in a first experiment, and then with PTH, parathyroid hormone-related peptide (PTHrP), or vehicle for 3 weeks in a second experiment. Both femurs from each rat were subjected to soft X-ray, computerized tomography (CT), and histological analysis, and the concentration of serum osteocalcin was determined. The femurs were also subjected to biomechanical testing.

The results showed that after two weeks, X-rays of the rats showed that new bone had begun to form in the bone marrow cavity. PTH increased trabecular density in the left femur, but failed to induce bone formation in the medullary region of the right unoperated femoral shafts. The newly formed bone endowed left femoral shafts with improved biomechanical properties when compared to those of right femurs and left femurs from control, sham-operated, and vehicle-treated rats. In the rats treated with PTH, new bone continued to grow in the cavity into the third week and the marrow did not return. The study was published in the February 2008 issue of Tissue Engineering (part A).

"Our results reveal that the newly formed bone that follows marrow ablation is responsive to PTH, expand the role of PTH in bone, and might open new avenues of investigations to the field of regenerative medicine and tissue engineering,” concluded lead author Agnes Vignery, D.D.S., Ph.D., and colleagues of the department of orthopedics and rehabilitation. "Local bone marrow removal in conjunction with pharmacologic intervention with an anabolic agent might provide a technique for rapid preferential site-directed bone growth in areas of high bone loss.”


Related Links:
Yale University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Glucose Meter
StatStrip®
New
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.